Trinity Biotech reported $-35180000 in Equity Capital and Reserves for its fiscal quarter ending in December of 2024.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Bio-Rad Laboratories USD 7.13B 449.3M Jun/2025
EDAP TMS EUR 40.9M 1.75M Dec/2024
J&J USD 78.11B 6.62B Mar/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Siemens EUR 60.59B 2.59B Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025
Tosoh JPY 811.64B 90.78B Jun/2025
Trinity Biotech USD -35180000 8.84M Dec/2024
Veracyte USD 1.22B 26.12M Jun/2025